These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of the purinergic pathway prolongs mouse lung allograft survival. Liu K; Vergani A; Zhao P; Ben Nasr M; Wu X; Iken K; Jiang D; Su X; Fotino C; Fiorina P; Visner GA Am J Respir Cell Mol Biol; 2014 Aug; 51(2):300-10. PubMed ID: 24661183 [TBL] [Abstract][Full Text] [Related]
5. Graft-Infiltrating Macrophages Adopt an M2 Phenotype and Are Inhibited by Purinergic Receptor P2X7 Antagonist in Chronic Rejection. Wu C; Zhao Y; Xiao X; Fan Y; Kloc M; Liu W; Ghobrial RM; Lan P; He X; Li XC Am J Transplant; 2016 Sep; 16(9):2563-73. PubMed ID: 27575724 [TBL] [Abstract][Full Text] [Related]
6. The P2X7 receptor antagonist, oxidized adenosine triphosphate, ameliorates renal ischemia-reperfusion injury by expansion of regulatory T cells. Koo TY; Lee JG; Yan JJ; Jang JY; Ju KD; Han M; Oh KH; Ahn C; Yang J Kidney Int; 2017 Aug; 92(2):415-431. PubMed ID: 28396117 [TBL] [Abstract][Full Text] [Related]
7. Blocking the monocyte chemoattractant protein-1/CCR2 chemokine pathway induces permanent survival of islet allografts through a programmed death-1 ligand-1-dependent mechanism. Lee I; Wang L; Wells AD; Ye Q; Han R; Dorf ME; Kuziel WA; Rollins BJ; Chen L; Hancock WW J Immunol; 2003 Dec; 171(12):6929-35. PubMed ID: 14662900 [TBL] [Abstract][Full Text] [Related]
8. Blockage of P2X7R suppresses Th1/Th17-mediated immune responses and corneal allograft rejection via inhibiting NLRP3 inflammasome activation. Fan X; Zhang J; Dai Y; Shan K; Xu J Exp Eye Res; 2021 Nov; 212():108792. PubMed ID: 34656546 [TBL] [Abstract][Full Text] [Related]
9. Murine islet allograft tolerance upon blockade of the B-lymphocyte stimulator, BLyS/BAFF. Parsons RF; Yu M; Vivek K; Zekavat G; Rostami SY; Ziaie AS; Luo Y; Koeberlein B; Redfield RR; Ward CD; Migone TS; Cancro MP; Naji A; Noorchashm H Transplantation; 2012 Apr; 93(7):676-85. PubMed ID: 22262127 [TBL] [Abstract][Full Text] [Related]
10. Islet allograft rejection in sensitized mice is refractory to control by combination therapy of immune-modulating agents. Hong J; Yeom HJ; Lee E; Han KH; Koo TY; Cho B; Ro H; Oh KH; Ahn C; Yang J Transpl Immunol; 2013 Mar; 28(2-3):86-92. PubMed ID: 23357716 [TBL] [Abstract][Full Text] [Related]
11. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo. Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046 [TBL] [Abstract][Full Text] [Related]
12. P2X7 purinoceptors contribute to the death of Schwann cells transplanted into the spinal cord. Luo J; Lee S; Wu D; Yeh J; Ellamushi H; Wheeler AP; Warnes G; Zhang Y; Bo X Cell Death Dis; 2013 Oct; 4(10):e829. PubMed ID: 24091672 [TBL] [Abstract][Full Text] [Related]
13. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice. Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475 [TBL] [Abstract][Full Text] [Related]
14. The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Abdi R; Smith RN; Makhlouf L; Najafian N; Luster AD; Auchincloss H; Sayegh MH Diabetes; 2002 Aug; 51(8):2489-95. PubMed ID: 12145162 [TBL] [Abstract][Full Text] [Related]
15. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells. Nasr IW; Wang Y; Gao G; Deng S; Diggs L; Rothstein DM; Tellides G; Lakkis FG; Dai Z J Immunol; 2005 May; 174(10):6161-8. PubMed ID: 15879112 [TBL] [Abstract][Full Text] [Related]
16. Arsenic Trioxide Induces T Cell Apoptosis and Prolongs Islet Allograft Survival in Mice. Gao C; Jiang J; Ma P; Cheng P; Lian Y; Zhao B; Li C; Peng Y; Wang F; Lin Y; Jin N; Li J; Wang L; Li Q; Leng Y; Xia J; Qi Z Transplantation; 2015 Sep; 99(9):1796-806. PubMed ID: 25919768 [TBL] [Abstract][Full Text] [Related]
17. Oxidized-ATP Attenuates Kidney Allograft Rejection By Inhibiting T-Cell, B-Cell, and Macrophage Activity. Ding X; Wilson NA; Redfield RR; Panzer SE; Verhoven B; Reese SR; Zhong W; Shi L; Burlingham WJ; Denlinger LC; Djamali A Kidney360; 2020 Feb; 1(2):106-114. PubMed ID: 35372912 [TBL] [Abstract][Full Text] [Related]
18. Inducible IL-7 Hyperexpression Influences Lymphocyte Homeostasis and Function and Increases Allograft Rejection. Schreiber M; Weigelt M; Karasinsky A; Anastassiadis K; Schallenberg S; Petzold C; Bonifacio E; Kretschmer K; Hommel A Front Immunol; 2019; 10():742. PubMed ID: 31024566 [TBL] [Abstract][Full Text] [Related]
19. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y; Tang XD; Zhou PJ Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744 [TBL] [Abstract][Full Text] [Related]